A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition

Clinical trial NCT07184385 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07184385
Sponsor: StemCyte, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Long COVID Post-COVID-19 Condition Post-COVID Syndrome Post-COVID Condition

Start date: 2026-03-31
Primary completion: 2027-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.